Content area
Full Text
Survival and Neurodevelopment among Periviable Infants
This study assessed survival and neurodevelopmental outcomes among infants born at 22 to 24 weeks of gestation, as measured at 18 to 22 months of corrected age, and showed that the rate of survival without neurodevelopmental impairment increased between 2000 and 2011.
see Original Article, N Engl J Med 2017;376:617-628
Osimertinib in EGFR-Mutated Lung Cancer
In a randomized trial involving patients with non–small-cell lung cancer with mutant EGFR (T790M) in whom a tyrosine kinase inhibitor had failed, osimertinib was associated with significantly longer progression-free survival than platinum therapy plus pemetrexed.
see Original Article, N Engl J Med 2017;376:629-640
Bariatric Surgery or Medical Therapy for Type 2 Diabetes
Five-year data showed that among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective than intensive medical therapy alone in decreasing or resolving hyperglycemia, even among those with a BMI of less than 35.
see Original Article, N Engl J Med 2017;376:
Baricitinib in...